These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 16462059
21. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825 [Abstract] [Full Text] [Related]
22. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Brniak W, Jachowicz R, Krupa A, Skorka T, Niwinski K. Pharm Dev Technol; 2013 Dec 01; 18(2):464-74. PubMed ID: 22881600 [Abstract] [Full Text] [Related]
27. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. Kuno Y, Kojima M, Ando S, Nakagami H. J Control Release; 2005 Jun 20; 105(1-2):16-22. PubMed ID: 15955365 [Abstract] [Full Text] [Related]
28. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation. Sano S, Iwao Y, Kimura S, Itai S. Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765 [Abstract] [Full Text] [Related]
30. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug. Comoglu T, Unal B. Pharm Dev Technol; 2015 Jan 15; 20(1):60-4. PubMed ID: 24295202 [Abstract] [Full Text] [Related]
32. Water-solid interactions. III. Effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone. Stubberud L, Arwidsson HG, Hjortsberg V, Graffner C. Pharm Dev Technol; 1996 Jul 15; 1(2):195-204. PubMed ID: 9552346 [Abstract] [Full Text] [Related]
33. Further improvement of orally disintegrating tablets using micronized ethylcellulose. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608 [Abstract] [Full Text] [Related]
34. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. Samvedna S, Jindal S, Mishra G, Madan JR, Gupta G, Awasthi R, Pinto TJA, Dua K, Kulkarni GT. Polim Med; 2018 Feb 28; 48(1):31-40. PubMed ID: 30657656 [Abstract] [Full Text] [Related]
35. Cold extrusion as a continuous single-step granulation and tabletting process. Keleb EI, Vermeire A, Vervaet C, Remon JP. Eur J Pharm Biopharm; 2001 Nov 28; 52(3):359-68. PubMed ID: 11677078 [Abstract] [Full Text] [Related]
36. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability. Bowles BJ, Dziemidowicz K, Lopez FL, Orlu M, Tuleu C, Edwards AJ, Ernest TB. AAPS PharmSciTech; 2018 Aug 28; 19(6):2598-2609. PubMed ID: 29916193 [Abstract] [Full Text] [Related]